DR. MORDECHAI FENIKEL BAR MD NPI 1174592455

NPI Information

  • NPI: 1174592455
  • Provider Name: DR. MORDECHAI FENIKEL BAR, MD
  • Classification: Internal Medicine - 207R00000X
  • Entity Type: Individual
  • Address: 110 LOCKWOOD AVE STE 401
    NEW ROCHELLE, NY
    ZIP 10801
  • Phone: (914) 576-2828

Map and Directions

Get Directions

NPI Details

DR. Mordechai Fenikel Bar, MD is an internal medicine in New Rochelle, NY. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Mordechai Fenikel Bar, MD NPI is 1174592455. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

110 LOCKWOOD AVE STE 401
NEW ROCHELLE, NY
ZIP 10801-013
Phone: (914) 576-2828

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
  • Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes (HCPCS:99336)
  • Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
  • Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
  • Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes (HCPCS:99335)
  • Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
  • Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes (HCPCS:99334)
  • Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes (HCPCS:99458)
  • Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
  • Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)
  • Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
  • Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
  • Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
  • New patient custodial care facility, group care, or assisted living visit, typically 1 hour (HCPCS:99327)
  • Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital duri (HCPCS:M0244)
  • Injection, casirivimab and imdevimab, 2400 mg (HCPCS:Q0243)
  • Injection, casirivimab and imdevimab, 1200 mg (HCPCS:Q0244)

The enumeration date for this NPI number is 3/17/2006 and was last updated on 12/12/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine195457-1NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1F94161MEDICARE UPIN
295F751MEDICARE PINNEW YORK
301500994MEDICAIDNEW YORK

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.